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Cell growth is regulated by two antagonistic processes: TOR signaling and autophagy. These pro-
cesses integrate signals including growth factors, amino acids, and energy status to ensure that cell
growth is appropriate to environmental conditions. Autophagy responds indirectly to the cellular
milieu as a downstream inhibitory target of TOR signaling and is also directly controlled by nutrient
availability, cellular energy status, and cell stress. The control of cell growth by TOR signaling and
autophagy are relevant to disease, as altered regulation of either pathway results in tumorigenesis.
Here we give an overview of how TOR signaling and autophagy integrate nutritional status to reg-
ulate cell growth, how these pathways are coordinately regulated, and how dysfunction of this reg-
ulation might result in tumorigenesis.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
In order to reproduce efﬁciently, eukaryotic cells must grow in a
manner appropriate to the extracellular milieu. For single-celled
organisms, the decision to grow and divide is simple. In the pres-
ence of appropriate nutrients (glucose and amino acids), the cell
will increase its size and mass and ultimately divide. Though the
decision to grow and divide in multicellular organisms is compli-
cated by the need for responsiveness to cell-to-cell signals and hor-
monal cues, much of the biological machinery required to respond
to those cues remains highly conserved. One such conserved path-
way is autophagy, which represents the major mechanism by
which a cell catabolizes biological macromolecules [47]. This can
happen for small amounts of cytosol or speciﬁc proteins through
direct fusion with the lysosome (i.e. microautophagy), the direct
receptor-mediated import of cytosolic proteins containing speciﬁc
recognition motif sequences into the lysosome (i.e. chaperone-
mediated autophagy) or it can occur through the de novo
formation of vesicles that engulf entire organelles and long-lived
proteins (i.e. macroautophagy). The focus of this review will be
the role of macroautophagy in the regulation of cellular growth
in metazoans (Table 1).
Although both increased cell size and cell proliferation contrib-
ute to cell growth, the rate of cell division is itself regulated bychemical Societies. Published by E
ious Diseases, UT Southwest-
ax: +1 214 648 0284.
B. Levine).changes in cell size. Thus, the regulation of cell size is of paramount
importance in regulating cellular growth. Increasing the mass of a
cell requires the net synthesis of macromolecules including pro-
teins, DNA, andRNA,whichultimately requires energy input. In con-
trast, the response to starvation or stress usually involves
macromolecular remodeling, energyproduction, and the catabolism
of existing macromolecules. The phosphatidylinositol 3-kinase
(PI3K)/TORpathwayhas emergedas the central conduit for integrat-
ing a variety of signaling pathways to promote cell growth and pro-
tein synthesis; autophagy is the primary pathway for catabolic
activities [24,25]. From a teleological perspective, an efﬁcient sys-
tem would couple the control of autophagy with the control of cell
growth, and cues thatpromoteonewould inhibit theother, thuspre-
venting inefﬁcient use of energy andnutrients. Indeed, both autoph-
agy and the PI3K signaling pathways have evolved to respond to a
variety of cellular growth and nutrient signals including growth fac-
tors, the presence of amino acids, and the presence of glucose and
energy. In addition, autophagy limits cellular growth and promotes
survival during cellular stress. Given the tightly intertwined pro-
cesses that are governed by TOR signaling and autophagy, it is
perhaps not surprising that extensive crosstalk and coordination be-
tween these pathways are now being unraveled (Figs. 1 and 2).2. Insulin/growth factors
Anabolic hormones (e.g. insulin and growth factors) regulate
cell growth by positively activating TOR signaling and inhibitinglsevier B.V. All rights reserved.
Table 1
Summary of roles of autophagy genes in cellular growth control.
Organism Relevant gene(s) mutation* Phenotype References
C. elegans unc-51 (Atg1/ULK); bec-1 (Atg6/beclin
1)
Decreased worm length** [3]
daf-2 (Igf-1) Increased cell size rescued by unc-51 or bec-1 mutants [3,62]
Drosophila Atg1 (ULK) overexpression Decreased cell size [84]
Atg1/ Normal cell size in well-fed animals; increased size in rapamycin-treated animals [84]
Mammalian Atg1/, dTOR Atg1/ partially rescues the decreased cell size of dTOR mutants [44]
Atg5/ (mouse cell lines) Increased cell size of starved ﬁbroblasts; no change in cell cycle proﬁle; no impairment of
entry into quiescence
[28,97]
beclin 1+/ (mice) Increased proliferation in mammary epithelial cells and splenic germinal center lymphocytes [78]
Ambra1/ (mice) Increased cell proliferation in fetal brain [14]
Atg7 shRNA, Atg5 shRNA (human cell
lines)
Delayed onset of senescence [105]
* Gene names in other organisms listed in parentheses.
** Decreased cell size in autophagy-deﬁcient C. elegans is proposed to occur through impaired ability to utilize cytosolic materials for cell remodeling and elongated cell
shape.
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Fig. 1. Interrelations between TOR complex signaling, autophagy, and cell growth control. TORC1 signaling promotes cell growth through its effects both on increasing cell
proliferation and increasing cell size and potentially through its inhibitory effects on autophagy. TORC1 increases protein synthesis and cell size through intermediates such
as 4E-BP and S6K; it promotes cell proliferation at least in part through its effects on cyclin and cyclin-dependent kinase (CKD) inhibitors. In contrast, autophagy is believed to
inhibit cell growth at least in part by promoting protein and/or organelle turnover. In addition, autophagy may have indirect effects on inhibiting cell proliferation through
promoting senescence. Additional, not yet deﬁned, mechanisms may also contribute to the inhibitory effects of autophagy on cell proliferation. Note that the presence of
growth factors, nutrients, and sufﬁcient energy are all required for the full activation of TORC1 signaling, whereas the absence of any of these factors or other types of cellular
stressors are sufﬁcient to induce autophagy.
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conserved between both pathways (e.g. AMPK, TSC2, and Vps34).
Although TOR exists in two signaling complexes, TOR complex 1
(TORC1) and TOR complex 2 (TORC2), this discussion focuses on
the rapamycin-sensitive TORC1 which constitutes the primary
complex responsible for assessing the presence of nutrients and
growth factor signals to control protein translation and cell growth
[25,53]. Insulin is a well-characterized growth factor that signals
through the canonical PI3K-TOR pathway (Fig. 2). In the presence
of appropriate growth factors, receptor tyrosine kinases phosphory-
late targets (e.g. IRS1) to stimulate Class 1 PI3Ks to generate phospha-
tidylinositol 3,4,5-trisphosphate (PIP3) from phosphatidylinositol
4,5-bisphosphate (PIP2). The accumulation of PIP3 is inhibited by
PTEN, phosphatase and tensin homolog deleted on chromosome
ten, an important negative regulatory protein in the PI3K-TOR
pathway. The availability of PIP3 at the membrane results in the
activation of Akt which inhibits the tuberous sclerosis complex
(TSC1/TSC2). This heterodimeric complex promotes the GTPase
activity of Rheb, a Ras-related GTPase, which causes Rheb-GTP to
become Rheb-GDP. Rheb-GTP activates TORC1 kinase activitywhile Rheb-GDP inhibits the complex. The net effect of growth fac-
tor stimulation is the activation of Rheb-GTP and subsequently
TORC1. In addition to autophagy inhibition, some important down-
stream effects of the TORC1 pathway include the activation of ribo-
somal S6 protein kinase (S6K1), inhibition of elongation factor 4E
binding protein (4E-BP1), and subsequent activation of the eukary-
otic translation initiation factor 4E (eIF4E). These downstream
effectors are critical for ribosome production, protein translation,
and, ultimately, cell growth [56,100].
The central role of the PI3K-TOR pathway in regulating growth
control is relevant to human disease as the loss of TORC inhibitors
(e.g. PTEN, LKB1, TSC1/2) or constitutive activation of TORC (e.g.
hyperactive PI3K or Ras signaling) results in both sporadic cancers
and cancer predisposition syndromes [82,87]. For example, PTEN
ismutated in Cowden’s disease, a disease characterized bymucocu-
taneous lesions (tricholemmomas, oral papillomas, and acral kera-
totic papules), and mutations in PTEN also predispose to a variety
of other human cancers [39]. The tuberous sclerosis complex 1 or
2 aremutated in the eponymous syndrome characterizedby cutane-
ous ﬁbromas and hamartomatous growth of a variety of tissues [86].
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Fig. 2. Coordinated regulation of TORC1 signaling and autophagy. Schematic diagram depicting the different inputs that contribute to the regulation of TORC signaling and
autophagy and, ultimately, cell growth. Bold lines represent an activation or inhibition for which there is molecular evidence for a direct interaction. Thin lines represent
activation steps that are likely indirect. Some activation steps which have not yet been demonstrated in mammalian cells are marked with a question mark.
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growth factor withdrawal that induces autophagy. Early evidence
for a role for receptor tyrosine kinase signaling in autophagy inhi-
bition came from genetic studies in C. elegans. The loss of C. elegans
daf-2, an ortholog of the insulin-like receptor tyrosine kinase, in-
duces autophagy to mediate constitutive dauer formation, lifespan
extension, pathogen resistance and increased degradation of b-
amyloid peptide [15,19,23,34,63]. Similarly, in Drosophila, the
deletion of its insulin-like peptides (DILPs) induces autophagy
and severe growth retardation [108]. Besides insulin signaling,
the loss of other growth factor signaling also induces autophagy.
For example, when bound to its receptor, interleukin-3 (IL-3) in-
duces tyrosine phosphorylation and activates the MAPK cascade
within hematopoietic cell lines, and IL-3 withdrawal from immor-
talized, apoptosis-deﬁcient (Bax/Bak/) cells results in the
induction of autophagy [55]. In addition, the loss of EGFR signaling
or substrate detachment results in the induction of autophagy in
breast epithelial cells [16].
The identiﬁcation of mechanisms by which growth factor with-
drawal induces autophagy provided one of the earliest links be-
tween autophagy regulation and TORC signaling; evidence from
evolutionarily diverse model systems has consistently demon-
strated that the inhibition of autophagy by growth factors occurs
through the activation of the Class I PI3K-TORC signaling pathway
[4,76,80,85]. Although TORC1 activation is necessary and sufﬁcient
for the repression of autophagy in the presence of growth factors, it
has not been determined whether the de-repression of basal
autophagy is adequate to explain growth-factor-withdrawal-in-
duced autophagy, or whether additional signals (i.e. low energy
status or limiting nutrient availability) that may act in parallel of
TOR are required to activate autophagy more directly.3. Amino acids
Perhaps even more evolutionarily conserved than their re-
sponse to growth factors, TORC and autophagy are responsive to
the presence of environmental nutrients. Even in the presence of
adequate growth factor signals, TORC signaling requires the pres-
ence of intracellular amino acids, especially branched chain amino
acids like leucine, for maximal TOR activation [9,20]. The central
role of amino acids in regulating cell growth was highlighted by
the ﬁnding that L-glutamine positively regulates cell size by pro-
moting the import of leucine and other essential amino acids
through the SLC7A5/SLC3A2 bidirectional transporter [69]. When
intracellular amino acids are low, the binding of Rheb to mTORC1
is impaired in a manner that is independent of both TSC2 or even
GTP binding by Rheb [54,70,91].
Although the exact sensor(s) through which amino acids pro-
mote TORC1 activity remains ambiguous, recent studies have be-
gun to reveal the mechanism of its amino acid-dependent
signaling. The Rag-GTPases, a heterodimer of RagA/B-GTP with
RagC/D-GDP, have been identiﬁed as direct binding partners of
mTORC1 through Raptor and have been implicated in the amino
acid sensitivity of TORC1 signaling [40,83]. This regulation is
thought to occur not through the direct activation of mTOR, but
rather through the subcellular relocalization of mTORC1 com-
plexes to a vesicular compartment that also contains Rab7 [83]
(Fig. 2). It has been proposed that the Rag heterodimers promote
the amino acid-dependent signaling of TORC1 by bringing the com-
plex into the vicinity of farnesylated Rheb. However, the precise
endomembrane localizations of both TORC1 and Rheb and the
dynamics of their proposed localizations remain a matter of active
investigation [7,11,35,83].
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importance of lipid signaling and vesicle trafﬁcking in amino
acid-dependent TORC1 signaling. Vps34, a class III PI3 kinase
which phosphorylates phosphatidylinositol (PI) to form phosphati-
dylinositol 3-phosphate (PI3P), has been identiﬁed as an amino
acid-dependent activator of TORC [8,70] (Fig. 2). This role of
Vps34 membrane signaling in the regulation of TORC1 activation
is especially interesting given recent ﬁndings demonstrating a pos-
sible role for Beclin 1, an upstream regulator of autophagy and
binding partner of Vps34 in diverse functions in vesicle sorting
and membrane trafﬁcking [33,61,110]. Curiously, Vps34 is not re-
quired for TORC activation in Drosophila, so it is unclear whether
this regulation is evolutionarily conserved [36]. A high research
priority will therefore be to uncover the exact role of Vps34, Beclin
1, and other components of autophagosome/vesicle trafﬁcking in
crosstalk with TORC1 regulation and to further determine whether
this is conserved in all metazoans.
While amino acids are required for TORC activation, the absence
of amino acids induces autophagy through several mechanisms.
Nutrient starvation activates autophagy indirectly through the
inhibition of TORC1 signaling which acts to repress a complex con-
taining Atg13, focal adhesion kinase-interacting protein 200
(FIP200), and unc-51 like kinases 1 and 2 (ULK1/2) in nutrient rich
conditions; this regulation is likely important for the coordinated
regulation of autophagy and TORC1 signaling [27,37]. However,
signaling through the PI3K-TOR pathway is only one of many ways
in which autophagy is sensitive to amino acids.
Amino acid starvation has also been implicated in regulation of
autophagy through the Raf kinase signaling cascade. In this cas-
cade, in an amino acid-dependent manner, Raf-1 activates MEK1/
2 (MAPK/ERK kinase), which activates ERK1/2 (extracellular signal
regulated kinase 1 and ERK2 mitogen activated kinase). Erk kinases
phosphorylate GAIP, a Ga interacting protein, whose phosphoryla-
tion promotes its GAP activity on the a subunit of the Gi3 protein,
which ultimately promotes autophagy [72,74,87]. However, Raf is
also downstream of Ras, which inhibits autophagy through the
Class I PI3K-TOR signaling pathway [17]. It remains to be deter-
mined whether the contradictory regulation of autophagy by Ras
through its Raf-1 and PI3K-TOR effector arms represents a biolog-
ical checkpoint control or whether it is an artifact of particular cell
lines.
Amino acid deprivation also activates autophagy by signaling
through the eIF2a and ER stress/integrated stress response
[79,93] (Fig. 2). In a pathway conserved from yeast to mammals,
a limiting supply of amino acids results in uncharged tRNAs and
the activation of Gcn2 (general control non-derepressible-2) and
phosphorylation of eukaryotic translation initiation factor-2 on
its a subunit (eIF2a) [103,109]. Phosphorylated eIF2a in turn
inhibits eIF2B, a pentameric guanine nucleotide exchange factor,
from recycling eIF2 to its active GTP-bound state. Phosphorylation
of eIF2a also results in the upregulation of ATF4 (activating tran-
scription factor 4), a transcription factor which in turn activates a
transcriptional program to respond to diverse cellular stresses
through the induction autophagy genes, amino acid transporters,
anti-oxidant response proteins, and chaperones [22,26,65,68,98].
Given its broad role in response to cellular stress, it is not surpris-
ing that eIF2a is also a target for other stress kinases (e.g. PKR dur-
ing viral infection, PERK during the unfolded protein response) and
thus forms a common pathway for the activation of autophagy in
response to amino acid starvation and other cellular insults [93].4. Energy sensing/glucose
In addition to amino acids, cells must also be supplied with glu-
cose, fatty acids, or pyruvate to maintain a constant supply of ATP[56]. Both positive growth signaling and autophagy are closely
linked to available energy in the cell. This is largely sensed through
cellular levels of ATP. The primary energy-sensing pathway of the
cell is the well-characterized AMPK pathway [21]. AMPK is an
essential heterotrimeric kinase that is activated during times of en-
ergy depletion by increased ratios of AMP to ATP and inhibited by
the presence of glycogen. When AMP is bound to the regulatory c-
subunit, LBK1/STK11 can phosphorylate and activate the catalytic
a-subunit of AMPK. In contrast, the regulatory b-subunit can bind
to glycogen to inhibit AMPK activity. The net effect of AMPK acti-
vation is the upregulation of the energy-producing pathways (e.g.
Glut4 receptors, insulin sensitivity) and inhibition of energy stor-
age pathways (e.g. glycogen synthesis, lipid synthesis) (Fig. 2).
AMPK inhibits the TORC1 complex by phosphorylating TSC2, which
then activates the GAP activity of TSC1/2 on Rheb-GTP favoring the
formation of the Rheb-GDP, thereby inactivating TORC1 [31]. In a
parallel inhibitory pathway, AMPK also phosphorylates and inhib-
its the TORC1-deﬁning component, Raptor, leading to an interac-
tion between Raptor and 14-3-3 that disrupts its binding to TOR
[18]. Mutations in LKB1/STK11 cause Peutz–Jeghers, which is char-
acterized by pigmentary abnormalities and a predisposition to
malignancy [21,31].
In a manner similar to growth factor withdrawal, the inhibition
of TORC1 signaling by active AMPK can indirectly induce autoph-
agy through a de-repression of the upstream regulators of the cat-
abolic process. Evidence from yeast suggests that AMPK also has a
more direct role in the induction of autophagy. Snf1, the yeast
homolog of AMPK, promotes autophagy by acting on Atg1 and
Atg13, yeast homologs of ULK and Atg13, respectively [101]. How-
ever, a direct role for AMPK in autophagy activation in mammalian
cells has not been demonstrated. In fact, early work in mammalian
cells suggested that AMPK inhibits autophagy [81]. However, more
recent work suggests that, similar to yeast, AMPK induces autoph-
agy [60,64].
5. Cell stress
In addition to being responsive to cellular growth cues, autoph-
agy is also critical for limiting cell growth and promoting cell sur-
vival in times of stress. Much of the cellular stress response has
converged on signaling through the ER through the unfolded pro-
tein response. Mammalian cells possess three ER transmembrane
receptors (IRE1a, ATF6, and PERK) that are responsible for trans-
ducing stress responses [6,79]. IRE1a and PERK are best character-
ized with respect to their ability to regulate autophagy.
IRE1a, inositol-requiring protein-1a, represents the most con-
served core of the unfolded protein response. Upon activation by
ER stress, IRE1a autophosphorylation induces a conformational
change allowing it to bind to the adaptor protein tumour necrosis
factor-a (TNF-a)-receptor-associated factor 2 (TRAF2) through its
cytoplasmic domain [96]. The recruitment of TRAF2 has been
shown to be important in stimulating autophagy in response to
the UPR via its activation of c-Jun NH(2)-terminal kinase (JNK)
[71]. In turn, JNK-mediated phosphorylation of Bcl-2 and disrup-
tion of the Bcl-2/Beclin 1 complex, and JNK-mediated upregulation
of Beclin 1 transcription likely contribute to the induction of
autophagy [48,73,102].
In a parallel pathway to JNK activation, IRE1a–TRAF2 com-
plexes also recruit IjB kinase (IKK) [30]. Active IKK induces
autophagy in a nuclear factor-jB (NF-jB) transcription-indepen-
dent manner [10]. Strikingly, the absence of IKK results in impaired
induction of autophagy suggesting that IKK-mediated induction of
autophagy is not redundant with other ER stress signaling path-
ways. Although IKK activation appears to inhibit TOR signaling
and induce AMPK and JNK, it is still unclear precisely how IKK acti-
vation promotes autophagy.
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pears to be transcription-dependent. In response to unfolded pro-
teins, PERK can phosphorylate eIF2a which then activates the
transcriptional upregulation of autophagy as noted previously
[43]. As already noted, other kinases capable of sensing cell stress,
including GCN2 and interferon-induced double-stranded RNA-
dependent protein kinase R (PKR), can also activate eIF2a in re-
sponse to conditions like amino acid deprivation and viral infection
[43,93]. Finally, as the major site of intracellular calcium storage,
ER stress also results in the release of intracellular calcium stores.
This release may result in the activation of autophagy through the
CaMKKb-dependent activation of AMPK [29].
Because the ER has the ability to integrate diverse cell stress sig-
nals including starvation, hypoxia, misfolded proteins, and infec-
tion, it is teleologically well-placed as a sensor to limit cell
growth during times of stress. A prominent role for ER stress in
limiting cell growth is consistent with a current model in which
the ER is thought to be the source of membranes for autophagoso-
mal structures [5]. Although it is known that Bcl-2 inhibits autoph-
agy through a direct interaction with the BH3 domain of Beclin 1,
the precise mechanistic details of this inhibition are unclear
[75,90]. Given that ER-localized Bcl-2 is the form that inhibits Be-
clin 1 autophagy function, and the recent ﬁnding that preauto-
phagosomal structures originate from the ER membrane, it is
possible that Bcl-2 sequesters Beclin 1 in ER membrane subdo-
mains away from preautophagosomal structures in the ER [5].
According to this model, in response to cell stress, the phosphory-
lation of Bcl-2 and its subsequent dissociation from the Beclin 1/
Vps34 complex may contribute to the initiation of autophagosomal
membrane formation.
6. Crosstalk between autophagy and TOR signaling
Direct interactions between the TORC1 and autophagy path-
ways help to coordinate the respective anabolic and catabolic pro-
cesses. As noted above, part of the coordinate regulation occurs
through TORC1-dependent phosphorylation and inactivation of a
complex containing Atg13, FIP200, and ULK1/2 [27,37]. When
TOR signaling is suppressed (e.g. growth factor withdrawal, starva-
tion, or pharmalogical treatment), ULK becomes activated and
phosphorylates and activates Atg13 and FIP200 to induce autoph-
agy. As the ULK–Atg13–FIP200 complex functions upstream in
autophagy, it is likely that the direct inhibitory phosphorylation
of this complex by TORC1 represents an important signaling step.
The precise mechanism through which the ULK–Atg13–FIP200
complex induces autophagy in metazoans remains to be
determined.
Although the regulation of autophagy is clearly downstream of
TOR signaling, there is increasing evidence that autophagy may
also regulate TOR signaling. Positive regulators of autophagy inhi-
bit activation of the TOR pathway (e.g. ULK1, Atg13) as assessed by
the phosphorylation of downstream targets of TOR like S6K1
[37,44]. The ﬁnding that Vps34 may be important for the amino
acid sensitive signaling through TORC suggests additional coordi-
nation in the regulation of autophagy and cellular growth [8,70].
At ﬁrst glance, it would appear that the cell growth-promoting
properties of Vps34 would seem to conﬂict with its role in initiat-
ing autophagic vesicle nucleation to regulate autophagy. However,
this apparent discrepancy may represent the function of distinct
complexes of Beclin 1/Vps34 with different functions. For example,
Vps34 forms a complex with Beclin 1 and Atg14 (also known as
Atg14L, Barkor) to positively regulate autophagosome formation
and maturation [33,61]. Beclin 1 also forms Atg14-independent
distinct complexes with UVRAG and Rubicon with possible roles
in the regulation of autophagosome/endosome maturation; how-ever, the precise functions of these complexes is unclear
[49,50,61,110].
Another interesting interface between PI3K-TOR signaling and
autophagy resides in the regulation of PI and its derivatives by dif-
ferent classes of PI3Ks. Class I and Class III PI3Ks share structural
similarities and both exist as a heterodimers of a catalytic (p110
and Vps34) and a regulatory (p85 and Vps15) subunit, respectively.
Both PI3Ks are crucial upstream regulatory kinases in their respec-
tive signaling cascades. In PI3K-TOR signaling, the conversion of
PIP2 to PIP3 is essential for the downstream activation of the
PIP3-dependent kinases, PDK and Akt. Similarly, in autophagy,
the conversion of PI to PI3P by the Beclin 1/Vps34 complex appears
to be one of the earlier, if not the earliest, signaling event in the
budding of the omegasome from the endoplasmic reticulum and
the eventual formation of the autophagosome [5]. In another inter-
esting parallel, both signaling pathways possess lipid phosphatases
(PTEN and Jumpy), which inhibit the activation of their respective
pathways [99]. Although the role of PIs in PI3K-TOR signaling and
in autophagy has been studied, little is known about how the two
pathways may interface at the level of lipid signaling. For example,
it will be a critical to determine whether the activity of Beclin 1/
Vps34 at autophagosomes in generating PI3P ultimately affects
the generation of PIP3 by Class I PI3Ks. Given the known crosstalk
between Vps34 and TORC signaling, the possible role of PI deriva-
tives in this crosstalk demands further attention.
Distinct from its activity in generating PI3P, Beclin 1/Vps34 may
function in other roles to affect TORC signaling. For example, given
the recent the recent ﬁnding that TORC1 relocalizes to Rab7-con-
taining vesicles upon activation, it is possible that autophagy and
cell growth could be coordinated through the action of different
Beclin 1/Vps34 complexes on different subsets of the endomem-
brane system. In amino acid and growth factor replete conditions,
the Beclin 1/Vps34 complexes would hypothetically act on endo-
somes/lysozomes to regulate TOR signaling complexes by ensuring
the appropriate maturation and recycling of TORC1-, Rheb-GTP-,
Rag-GTPase-containing vesicles. In contrast, upon depletion of
amino acids, the Beclin 1/Vps34 complexes might localize to spe-
ciﬁc sites in the endoplasmic reticulum (ER) membranes where
they would promote the generation of PI3P to initiate the forma-
tion of the autophagic isolation membrane. Clearly, more experi-
ments are necessary to understand the role of the Beclin 1/Vps34
complex in regulation of endomembrane trafﬁcking and how it
may affect TORC signaling.
7. Emerging functions of autophagy in cell cycle control
As cell division contributes to cell growth, cell cycle checkpoints
are a critical regulatory point in the growth control of eukaryotes.
The decision to enter S phase from G1 is promoted by cyclin-
dependent kinase (CDK)/cyclin complexes (e.g. cyclin D/Cdk4 and
cyclin E/Cdk2) which are inhibited by CDK inhibitors (CDKIs)
including p16 and p27. The levels of both CDK/cyclins and CDKIs
are regulated through ubiquitination [89]. TORC1 signaling has
been shown to contribute to cell cycle regulation through affecting
the levels of both cyclins and CDKIs [100].
Less is known about the relationship between the cell cycle and
autophagy. Experiments using pharmacologically synchronized
cells have demonstrated that autophagy is most active in the G1
and S phases of the cell cycle, while it is inhibited in mitosis
[12,95]. Speciﬁc regulators of the cell cycle have also been shown
to affect autophagy. For example, p14ARF, an alternative reading
frame product of the p16 locus and inhibitor of G1 cell cycle pro-
gression, binds to Bcl-XL, a Bcl-2 anti-apoptotic family member;
this binding disrupts Beclin 1/Bcl-XL binding and induces autoph-
agy [77]. Also, the overexpression of the CDKI, p27, is sufﬁcient
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AMPK) and amino acid starvation have both been shown to stabi-
lize p27 [45,51] suggesting a possible role for p27 in the physiolog-
ical regulation of autophagy. However, our understanding of the
impact of the cell cycle on autophagy is in its infancy, and the
mechanisms through which cell cycle regulators, like p14ARF and
p27, promote autophagy remain an important area of continued
research.
In addition to ties to the canonical cell cycle, there is also evi-
dence for a direct role for autophagy in executing cellular senes-
cence. Cellular senescence is a form of irreversible cell cycleDecreased
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possibly through the accumulation of damaged organelles and increased ROS [38,58,59]
survival of tumor cells in response to metabolic stress in the tumor microenvironment. I
that are hyperproliferative are depicted as dark blue; and transformed cells are depicted a
size [28,55] which is depicted in this ﬁgure; however, multiple factors other than levels
Senescent cells display a large and ﬂattened morphology.arrest; it can be induced by exogenous DNA damage, telomere
depletion, or oncogene (e.g. Ras or MEK) overexpression. This path-
way is proposed to contribute to tumor suppression by inhibiting
the proliferation of otherwise damaged cells. Oncogene expression
induces the transcriptional upregulation of many mediators of
autophagy, and the inhibition of autophagy delays the onset of
senescence [105].
Although there is no direct evidence that the genetic disruption
or pharmacologic inhibition of autophagy has strong effects on cell
cycle regulation, experimental mouse models indicate that
deﬁciency of some autophagy proteins such as Beclin 1 and senescence
STRESS
(nutrient starvation, 
damaged organelles, 
misfolded proteins, 
DNA damage, etc.)
STRESS
(nutrient starvation, 
damaged organelles, 
misfolded proteins, 
DNA damage, etc.)
Prolonged stress
results in cell death
and cell senescence
Upregulation of autophagy
x x
x
STRESS
(tumor microenvironment,
chemotherapeutics) 
) In normal tissues, autophagy functions to promote cell survival in response to a
isfolded proteins. If the stressor is irreparable, the cell has a number of mechanisms
tic cell death, and senescence. (B) In autophagy-deﬁcient tissues, a cell is unable to
origenesis. (1) Autophagy has a role in the induction of senescence [105] and non-
ential tumor suppressor mechanisms. (2) Decreased autophagy has also been shown
reased autophagy results in increased chromosomal instability and mutagenesis
. In contrast, the upregulation of autophagy in established tumors may promote the
n this ﬁgure, normal cells are depicted as light blue; cells with decreased autophagy
s red. In general, there is an inverse correlation between levels of autophagy and cell
of autophagy contribute to the increased nuclear/cytoplasmic ratio of tumor cells.
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emerging important role for autophagy in the degradation of ubiq-
uitinated targets through speciﬁc receptor molecules (e.g. p62/
SQSTM1), it is possible that autophagy plays a role in the degrada-
tion of cell signaling molecules subject to ubiquitination [41]. The
loss of autophagy might result in the abnormal persistence of these
cell cycle regulators (e.g. CDKIs) and result in aberrant cell cycle
entry. While there is growing evidence for a role of autophagy in
the control of cell proliferation, more work is required to deﬁne
the mechanism(s) by which this occurs.
8. Autophagy and tumor suppression
One clinically important sequelae of dysfunction of cellular
growth control is tumorigenesis. Although the role of hyperactiva-
tion of the PI3K/TOR pathway in promoting tumorigenesis is well-
established, the contribution of autophagy to tumor suppression is
only now being established [87]. Activators of TOR signaling (e.g.
Class I PI3K, Akt, and Ras) function as oncogenes while inhibitors
(e.g. TSC1/2, PTEN, LKB1/AMPK) function as tumor suppressors.
In contrast, activators of autophagy (e.g. LKB1/AMPK, p27, DAPk,
PTEN, TSC1/2) function as tumor suppressors while inhibitors of
autophagy (e.g. Bcl-2, Akt, activated Class I PI3K) function as onco-
genes. Of note, the relationship of autophagy to the established tu-
mor suppressor p53 is less clear. Stress-induced (e.g. DNA damage)
activation of p53 induces autophagy, while basal levels of p53 ap-
pear to inhibit autophagy [13,46,94]. This apparent discrepancy
may relate to the diverse, context-speciﬁc functions of p53 in mul-
tiple signaling pathways that inﬂuence autophagy or to differing
nuclear and cytoplasmic functions of p53 [46]. Interestingly, about
1/3 of colon cancer-associated mutated forms of p53 accumulate in
the cytoplasm, and inhibit autophagy, suggesting a mechanism by
which mutation of p53 in human cancer may impair autophagy
[67]. Thus, despite some conﬂicting data regarding p53-dependent
control of autophagy, taken together, the preponderance of evi-
dence suggests that autophagy may be a critical downstream effec-
tor of multiple signaling pathways relevant to tumorigenesis.
Several studies in mammalian systems have conﬁrmed the
importance of autophagy execution genes in tumor suppression.
Beclin 1 and UVRAG (a potential activator of Beclin 1-dependent
autophagy) inhibit tumor cell growth in vitro and tumor xenograft
formation in vivo [52] Nature; [42,49]. Mouse models demonstrate
that the monoallelic loss of beclin 1 or Ambra1 or bi-allelic loss of
Bif-1 results in increased spontaneous tumorigenesis [78,92] (per-
sonal communication, F. Cecconi) and Atg4c/ null mice demon-
strate increased chemically induced ﬁbrosarcomas. [57].
Furthermore, monoallelic deletions of UVRAG are common in hu-
man colon cancer [32] and monoallelic deletions of beclin 1 are
common in human breast, ovarian, and prostate cancer [2,32]. In
addition, decreased Beclin 1 expression has been linked to ad-
vanced tumor grade and/or poor survival prognosis in several types
of human cancer, including gastric carcinoma, hepatocellular carci-
noma, colon cancer, ovarian cancer, and brain tumors
[1,66,88,104]. Thus, there is emerging data suggesting that loss of
autophagy execution gene function may contribute to
tumorigenesis.
While the tumor suppressor function of autophagy is undis-
puted, the mechanistic details of how autophagy functions in tu-
mor suppression are still unclear (Fig. 3). The role of autophagy
in tumor suppression can be explained, in part, by its ability to pre-
vent chromosome instability. The loss of autophagy genes (e.g.
monoallelic loss of beclin 1, or biallelic loss of Atg5) promotes
DNA damage, gene ampliﬁcation, and aneuploidy in cell culture
and tumor xenograft models [59,38]. It is postulated that autoph-
agy protects cells from genomic instability by promoting the deg-radation of p62 and damaged organelles (e.g. mitochondria), and
by decreasing the accumulation of damaging ROS [38,58,59]. It re-
mains to be determined whether autophagy also regulates cellular
proteins that directly function in DNA damage repair. Regardless of
the mechanism by which autophagy prevents genomic instability,
this function of autophagy likely represents a critical part of its
ability to prevent tumorigenesis.
However, in addition to preventing genomic instability, there is
evidence that autophagy may function in additional parallel path-
ways to prevent tumorigenesis. Speciﬁcally, increased proliferation
of mammary epithelial cells and splenic lymphocytes has been
noted in beclin 1 heterozygous-deﬁcient mice and increased neural
cell proliferation has been noted in Ambra1-deﬁcient embryonic
mice [14,78]. The mechanism by which autophagy inhibits cell
proliferation is not clear. However, several known functions of
autophagy could theoretically contribute. First, autophagy has
been proposed to play a role in executing cellular senescence
[105], so the loss of autophagy might impair the induction of this
tumor suppressor mechanism in response to inappropriate mito-
genic signals or DNA damage. Second, a postulated role for autoph-
agy in limiting cell cycle progression could also be a tumor
suppressor mechanism. Third, as noted above, autophagy or spe-
ciﬁc autophagic proteins may function in limiting TOR signaling,
so the partial loss of autophagy could result in inappropriate sig-
naling through the TOR pathway, which is known to occur in
tumorigenesis. Finally, the loss of autophagy may also promote
tumorigenesis by providing selective pressures for cells that inap-
propriately amplify cellular growth signals. In a setting of nutrient
deprivation, individual cells of a multicellular organism usually
survive through the preferred method of autophagy and the catab-
olism of endogenous macromolecules for the generation of energy
and nutrients. Alternatively, individual cells could mutate and sur-
vive by developing a competitive advantage in nutrient uptake to
the detriment of its adjacent sibling cells. Mutations that improve
nutrient uptake have been shown to be tumorigenic (e.g. BRAF or
KRAS mutations) [107]. In this speculative model, autophagy-deﬁ-
cient cells would be under constant selective pressure for onco-
genic mutations to overcome their nutrient limitation.
9. Conclusion
Given its central role in integrating environmental signals like
the presence of sufﬁcient nutrients, energy, and growth factors,
the PI3K/TOR signaling pathway is often viewed as the principal
mediator of cellular growth control. More recently, autophagy
has emerged as a crucial player in the negative regulation of cellu-
lar growth. Although autophagy is regulated as a downstream tar-
get of TORC signaling, autophagy can also regulate cell growth in
response to distinct stimuli like amino acid depletion, energy
deprivation, and ER stress, independently of PI3K/TOR signaling.
Thus, TORC signaling and autophagy actually represent parallel,
but contrasting pathways that function together in a coordinated
manner to maintain homeostasis and growth control. The loss of
such control by either dysfunction of TOR signaling and/or autoph-
agy likely underlies the pathogenesis of most human cancers.
However, the precise mechanisms by which autophagy acts in cell
growth control and tumor suppression require further discovery
and ‘‘digestion”.
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